PubRank

Gabriele Neumann

Author PubWeight™ 92.12‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature 2009 14.59
2 Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets. Nature 2012 14.17
3 Characterization of H7N9 influenza A viruses isolated from humans. Nature 2013 3.71
4 Biological and structural characterization of a host-adapting amino acid in influenza virus. PLoS Pathog 2010 3.65
5 The potential for respiratory droplet-transmissible A/H5N1 influenza virus to evolve in a mammalian host. Science 2012 3.50
6 Ebolavirus is internalized into host cells via macropinocytosis in a viral glycoprotein-dependent manner. PLoS Pathog 2010 2.60
7 Human infection with highly pathogenic H5N1 influenza virus. Lancet 2008 2.57
8 Molecular determinants of Ebola virus virulence in mice. PLoS Pathog 2006 2.44
9 Tyro3 family-mediated cell entry of Ebola and Marburg viruses. J Virol 2006 2.24
10 Characterization of a human H5N1 influenza A virus isolated in 2003. J Virol 2005 2.09
11 Reassortment between avian H5N1 and human H3N2 influenza viruses creates hybrid viruses with substantial virulence. Proc Natl Acad Sci U S A 2010 1.56
12 Compatibility among polymerase subunit proteins is a restricting factor in reassortment between equine H7N7 and human H3N2 influenza viruses. J Virol 2008 1.55
13 Generation of biologically contained Ebola viruses. Proc Natl Acad Sci U S A 2008 1.47
14 In vitro and in vivo characterization of recombinant Ebola viruses expressing enhanced green fluorescent protein. J Infect Dis 2007 1.43
15 Mutational analysis of conserved amino acids in the influenza A virus nucleoprotein. J Virol 2009 1.40
16 Replication-deficient ebolavirus as a vaccine candidate. J Virol 2009 1.32
17 Ebola virus matrix protein VP40 uses the COPII transport system for its intracellular transport. Cell Host Microbe 2008 1.31
18 Immunogenicity and protective efficacy of replication-incompetent influenza virus-like particles. J Virol 2002 1.30
19 Host regulatory network response to infection with highly pathogenic H5N1 avian influenza virus. J Virol 2011 1.30
20 RAB11A is essential for transport of the influenza virus genome to the plasma membrane. J Virol 2011 1.29
21 Impact of amino acid mutations in PB2, PB1-F2, and NS1 on the replication and pathogenicity of pandemic (H1N1) 2009 influenza viruses. J Virol 2011 1.17
22 Selection on haemagglutinin imposes a bottleneck during mammalian transmission of reassortant H5N1 influenza viruses. Nat Commun 2013 1.17
23 Replication-incompetent influenza A viruses that stably express a foreign gene. J Gen Virol 2011 1.12
24 Rescue of Ebola virus from cDNA using heterologous support proteins. Virus Res 2004 1.12
25 Adding protein context to the human protein-protein interaction network to reveal meaningful interactions. PLoS Comput Biol 2013 1.10
26 A role for the C terminus of Mopeia virus nucleoprotein in its incorporation into Z protein-induced virus-like particles. J Virol 2010 1.10
27 Avian-type receptor-binding ability can increase influenza virus pathogenicity in macaques. J Virol 2011 1.09
28 Tissue-specific subnetworks and characteristics of publicly available human protein interaction databases. Bioinformatics 2011 1.07
29 Virulence-affecting amino acid changes in the PA protein of H7N9 influenza A viruses. J Virol 2013 1.06
30 The cytoprotective enzyme heme oxygenase-1 suppresses Ebola virus replication. J Virol 2013 1.03
31 Role of host-specific amino acids in the pathogenicity of avian H5N1 influenza viruses in mice. J Gen Virol 2009 1.02
32 The Ebolavirus VP24 protein blocks phosphorylation of p38 mitogen-activated protein kinase. J Infect Dis 2011 0.98
33 F1Fo-ATPase, F-type proton-translocating ATPase, at the plasma membrane is critical for efficient influenza virus budding. Proc Natl Acad Sci U S A 2012 0.96
34 A comprehensive map of the influenza A virus replication cycle. BMC Syst Biol 2013 0.93
35 Live bivalent vaccine for parainfluenza and influenza virus infections. J Virol 2005 0.91
36 Minigenome-based reporter system suitable for high-throughput screening of compounds able to inhibit Ebolavirus replication and/or transcription. Antimicrob Agents Chemother 2010 0.91
37 RuvB-like protein 2 is a suppressor of influenza A virus polymerases. J Virol 2009 0.90
38 Functional genomics reveals the induction of inflammatory response and metalloproteinase gene expression during lethal Ebola virus infection. J Virol 2011 0.89
39 The role of reverse genetics systems in studying viral hemorrhagic fevers. Thromb Haemost 2005 0.89
40 Synergistic effect of the PDZ and p85β-binding domains of the NS1 protein on virulence of an avian H5N1 influenza A virus. J Virol 2013 0.89
41 A network integration approach to predict conserved regulators related to pathogenicity of influenza and SARS-CoV respiratory viruses. PLoS One 2013 0.87
42 Characterization in vitro and in vivo of pandemic (H1N1) 2009 influenza viruses isolated from patients. J Virol 2012 0.87
43 Specific mutations in H5N1 mainly impact the magnitude and velocity of the host response in mice. BMC Syst Biol 2013 0.86
44 Functional analysis of conserved motifs in influenza virus PB1 protein. PLoS One 2012 0.86
45 Role of the GTPase Rab1b in ebolavirus particle formation. J Virol 2010 0.84
46 Human immunodeficiency virus rev-binding protein is essential for influenza a virus replication and promotes genome trafficking in late-stage infection. J Virol 2011 0.83
47 Phenotypic properties resulting from directed gene segment reassortment between wild-type A/Sydney/5/97 influenza virus and the live attenuated vaccine strain. Virology 2007 0.82
48 Mitogen-activated protein kinase-activated kinase RSK2 plays a role in innate immune responses to influenza virus infection. J Virol 2009 0.79
49 An M2 cytoplasmic tail mutant as a live attenuated influenza vaccine against pandemic (H1N1) 2009 influenza virus. Vaccine 2011 0.78
50 Influenza viruses: an introduction. Methods Mol Biol 2012 0.75